GeneTether Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.204338 million compared to USD 0.479662 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -.--% | -.--% | +12.50% |
1st Jan change | Capi. | |
---|---|---|
+12.50% | 1.27M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- GTTX Stock
- News GeneTether Therapeutics Inc.
- GeneTether Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023